A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients

NCT02253264 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Primary Progressive Multiple Sclerosis
Secondary Progressive Multiple Sclerosis

Interventions

DRUG: Rituximab

Sponsor

Johns Hopkins University